Charles River-CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up

Charles River Laboratories International, Inc. (CRL) reported first-quarter 2025 adjusted earnings per share (EPS) of $2.34, which rose 3.1% year over year. The figure surpassed the Zacks Consensus Estimate by 13.6%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar). On a GAAP basis, the company reported earnings of 50 cents per share compared with the year-ago quarter's EPS of$ 1.31. CRL's Q1 Revenues Revenues totaled $984.2 million, which beat the Zacks Consensus Estimate by 5.2%. H ...